Molecular diagnostics of gliomas: state of the art

Por Riemenschneider, Markus J., Jeuken, Judith W. M., Wesseling, Pieter, Reifenberger, Guido
Publicado em 2010

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Stu...

Por van den Bent, Martin J., Dubbink, Hendrikus J., Sanson, Marc, van der Lee-Haarloo, Cathleen R., Hegi, Monika, Jeuken, Judith W.M., Ibdaih, Ahmed, Brandes, Alba A., Taphoorn, Martin J.B., Frenay, Marc, Lacombe, Denis, Gorlia, Thierry, Dinjens, Winand N.M., Kros, Johan M.
Publicado em 2009

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone

Por Molenaar, Remco J., Verbaan, Dagmar, Lamba, Simona, Zanon, Carlo, Jeuken, Judith W.M., Boots-Sprenger, Sandra H.E., Wesseling, Pieter, Hulsebos, Theo J.M., Troost, Dirk, van Tilborg, Angela A., Leenstra, Sieger, Vandertop, W. Peter, Bardelli, Alberto, van Noorden, Cornelis J.F., Bleeker, Fonnet E.
Publicado em 2014